HVC
Healthcare Value Capital Portfolio holdings
AUM
$38.5M
1-Year Return
22.29%
This Quarter Return
-0.49%
1 Year Return
+22.29%
3 Year Return
+31.09%
5 Year Return
+125.72%
10 Year Return
–
AUM
$69.3M
AUM Growth
+$4.44M
(+6.8%)
Cap. Flow
+$6.62M
Cap. Flow
% of AUM
9.56%
Top 10 Holdings %
Top 10 Hldgs %
89.99%
Holding
35
New
5
Increased
5
Reduced
5
Closed
7
Top Buys
| 1 |
ProShares UltraShort Russell2000
TWM
|
$9.84M |
| 2 |
AGN
Allergan plc
AGN
|
$7.24M |
| 3 |
ANI Pharmaceuticals
ANIP
|
$4.27M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$2.35M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$1.13M |
Top Sells
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$4.6M |
| 2 |
Merck
MRK
|
$4.45M |
| 3 |
Sanofi
SNY
|
$3.07M |
| 4 |
AstraZeneca
AZN
|
$1.79M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$1.61M |
Sector Composition
| 1 | Healthcare | 77.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Galmed Pharmaceuticals
GLMD
$7.18M
| – | – |
-278
| Closed | -$487K |
|
27
iShares Russell 2000 ETF
IWM
$68B
| – | – |
0
| – | – |
|
|
28
Merck
MRK
$212B
| – | – |
-80,696
| Closed | -$4.45M |
|
|
29
Sanofi
SNY
$114B
| – | – |
-57,735
| Closed | -$3.07M |
|
30
SPDR S&P 500 ETF Trust
SPY
$663B
| – | – |
0
| – | – |
|
31
Supernus Pharmaceuticals
SUPN
$2.56B
| – | – |
0
| – | – |
|
|
VXRT
32
DELISTED
Vaxart
VXRT
| – | – |
-13,228
| Closed | -$415K |
|
|
IPXL
33
DELISTED
Impax Laboratories, Inc.
IPXL
| – | – |
-50,000
| Closed | -$1.5M |
|
|
AUXL
34
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| – | – |
-229,481
| Closed | -$4.6M |
|
|
VXX
35
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| – | – |
0
| – | – |
|